Motor-dominant chronic inflammatory demyelinating polyneuropathy

Journal of Neurology

Volumn 257, Issue 4, 2010, Pages 621-629

  Kimura, Akio ^a   Sakurai, Takeo ^a   Koumura, Akihiro ^a   Yamada, Megumi ^a   Hayashi, Yuichi ^a   Tanaka, Yuji ^a   Hozumi, Isao ^a   Yoshino, Hiide ^b   Yuasa, Tatsuhiko ^b   Inuzuka, Takashi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b 1 7 1 Kohnodai   (Japan)

Author keywords

Corticosteroid; IVIg; Motor dominant CIDP; Pure motor CIDP; Relapsing remitting

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; GADOLINIUM; IMMUNOGLOBULIN; MEPREDNISONE; PREDNISOLONE;

ADULT; AGED; AREFLEXIA; ARTICLE; BRACHIAL PLEXUS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG PULSE THERAPY; FEMALE; HAND PARESTHESIA; HUMAN; LIMB WEAKNESS; MALE; NERVE ROOT; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RELAPSE; SCORING SYSTEM; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION; TREATMENT DURATION; TREATMENT INDICATION;

ACTION POTENTIALS; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; ELECTROMYOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE, SKELETAL; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; STATISTICS, NONPARAMETRIC;

EID: 77951254983     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5386-x     Document Type: Article

References (15)

1. HW Sander N Latov 2003 Research criteria for defining patients with CIDP Neurology 60 8 15 (Pubitemid 36459464)
2. M Sabatelli F Media T Mignogna G Lippi L Quaranta P Tonali 2001 Pure motor chronic inflammatory demyelinating polyneuropathy J Neurol 248 772 777 10.1007/s004150170093 1:STN:280:DC%2BD3MrkvF2kug%3D%3D 11596782 (Pubitemid 32802112)
3. M Busby M Donaghy 2003 Chronic dysimmune neuropathy: A subclassification based upon the clinical features of 102 patients J Neurol 250 714 724 10.1007/s00415-003-1068-2 12796835 (Pubitemid 36718361)
4. UK Misra J Kalita RK Yadav 2007 A comparison of clinical atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy Eur Neurol 58 100 105 1:STN:280:DC%2BD2svmvFeqsQ%3D%3D 17565223 (Pubitemid 47237654)
5. Joint Task Force of the EFNS and the PNS 2005 European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society J Peripher Nerv Syst 10 220 228 10.1111/j.1085-9489.2005.10302.x (Pubitemid 41580029)
6. JC van Swieten PJ Koudstaal MC Visser HJ Schouten J van Gijn 1988 Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 604 607 3363593
7. N Hattori M Ichimura M Nagamatsu M Li K Yamamoto K Kumazawa T Mitsuma G Sobue 1999 Clinicopathological features of Churg-Strauss syndrome-associated neuropathy Brain 122 427 439 10.1093/brain/122.3.427 10094252 (Pubitemid 29110518)
8. N Hattori K Misu H Koike M Ichimura M Nagamatsu M Hirayama G Sobue 2001 Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy J Neurol Sci 184 57 63 10.1016/S0022-510X(00)00493-7 1:STN:280:DC%2BD3M3os1OjtQ%3D%3D 11231033 (Pubitemid 32166726)
9. A Kimura H Yoshino T Yuasa 2005 Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia J Neurol Sci 231 89 93 10.1016/j.jns.2004.12.012 1:STN:280:DC%2BD2M7mtVyksg%3D%3D 15792827 (Pubitemid 40432032)
10. E Nobile-Orazio 1996 Multifocal motor neuropathy J Neurol Neurosurg Psychiatry 60 599 603 10.1136/jnnp.60.6.599 1:STN:280:DyaK283ksFCrsQ%3D%3D 8648324 (Pubitemid 26237109)
11. P Federico DW Zochodne AF Hahn WF Brown TE Feasby 2000 Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study Neurology 55 1256 1262 1:CAS:528:DC%2BD3cXos12gtL4%3D 11087764
12. Olney RK, Lewis RA, Putnam TD, Campellone JV Jr, American Association of Electrodiagnostic Medicine (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Mus Nerv 27:117-121 (Pubitemid 36083455)
13. MD Kazatchkine SV Kaveri 2001 Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 747 755 10.1056/NEJMra993360 1:CAS:528:DC%2BD3MXmvFKjsLg%3D 11547745
14. MC Dalakas 2004 Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 2367 2375 10.1001/jama.291.19.2367 1:CAS:528: DC%2BD2cXkt1Sjsbo%3D 15150209 (Pubitemid 38656304)
15. JC Bystryn D Jiao 2006 IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris Autoimmunity 39 601 607 10.1080/08916930600972016 1:CAS:528:DC%2BD2sXhslShurg%3D 17101504 (Pubitemid 44768929)